Researchers from Enanta Pharmaceuticals Inc. presented preclinical data for the small molecule non-nucleoside respiratory syncytial virus (RSV) L-protein inhibitor, EDP-323, being developed for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback